Starling Oncology STLN
NASDAQ STLN
$5.97 -0.12 (-1.97%)
At close: Sep 3, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Gross Profit Growth (3y) (2024 - 2026)

Analysis

Starling Oncology (STLN) Gross Profit Growth (3y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn 5.82%
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn 4.02%
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn 9.79%
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 7.15%
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn 7.98%
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn 15.52%
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn 7.23%
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn 25.84%
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn 11.86%
10 Starling Oncology 609.95 Mn 568.85 Mn 27.17 Mn -8.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.40%
Mar 31, 2026 -11.27%
Dec 31, 2025 90.52%
Sep 30, 2025 -13.12%
Jun 30, 2025 -14.55%
Mar 31, 2025 -14.69%
Dec 31, 2024 88.51%
Sep 30, 2024 -18.85%
Jun 30, 2024 25.60%
Mar 31, 2024 21.00%